Spatial control of the βaR system in heart failure: The transverse tubule and beyond

Cardiovascular Research

Volumn 98, Issue 2, 2013, Pages 216-224

  Gorelik, Julia ^a   Wright, Peter T ^a   Lyon, Alexander R ^a,b   Harding, Sian E ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Beta adrenergic receptors; Cardiac; Cardiomyocyte; Heart failure; Sympathetic system; T tubules

Indexed keywords

ADRENALIN; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BIN1 PROTEIN; CAVEOLIN 1; CAVEOLIN 2; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; ISOBUTYLMETHYLXANTHINE; ISOPRENALINE; PERTUSSIS TOXIN; PHOSPHOLAMBAN; PROTEIN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; UNCLASSIFIED DRUG;

AORTA CONSTRICTION; APOPTOSIS; CALCIUM TRANSPORT; CELL COMPARTMENTALIZATION; CONGESTIVE CARDIOMYOPATHY; EXCITATION CONTRACTION COUPLING; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART PACING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INOTROPISM; ISCHEMIC CARDIOMYOPATHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; SYMPATHETIC INNERVATION; SYMPATHETIC TONE; TAKOTSUBO CARDIOMYOPATHY; TRANSVERSE TUBULAR SYSTEM; UPREGULATION;

AMINO ACID TRANSPORT SYSTEM Y+L; ANIMALS; CAVEOLAE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DISEASE MODELS, ANIMAL; HEART FAILURE; HUMANS; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; NEOPLASM PROTEINS; RECEPTORS, ADRENERGIC, BETA; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION;

EID: 84877253555     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvt005     Document Type: Review

References (99)

1. Xiao RP. {Beta}-adrenergic signaling in the heart: dual coupling of the {beta}2-adrenergic receptor to Gs and Gi proteins. Sci STKE 2001;2001:re15.
2. Brette F, Orchard C. T-tubule function in mammalian cardiac myocytes. Circ Res 2003; 92:1182-1192.
3. Kuschel M, Zhou YY, Cheng H, Zhang SJ, Chen Y, Lakatta EG et al. G(i) proteinmediated functional compartmentalization of cardiac beta(2)-adrenergic signaling. J Biol Chem 1999;274:22048-22052.
4. Engelhardt S, Hein L, Wiesmann F, Lohse MJ. Progressive hypertrophy and heart failure in b1-adrenergic receptor transgenic mice. Proc Natl Acad Sci USA 1999;96: 7059-7064.
5. Milano CA, Allen LF, Rockman HA, Dolber PC, McMinn TR, Chien KR et al. Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. Science 1994;264:582-586.
6. Liggett SB, Tepe NM, Lorenz JN, Canning AM, Jantz TD, Mitarai S et al. Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level. Circulation 2000;101:1707-1714.
7. Communal C, Singh K, Sawyer DB, Colucci WS. Opposing effects of b1-and b2-adrenergic receptors on cardiac myocyte apoptosis. Circulation 1999;100: 2210-2212.
8. Zhu WZ, Zheng M, Koch WJ, Lefkowitz RJ, Kobilka BK, Xiao RP. Dual modulation of cell survival and cell death by b2-adrenergic signaling in adult mouse cardiac myocytes. Proc Natl Acad Sci USA 2001;98:1607-1612.
9. Buxton IL, Brunton LL. Compartments of cyclic AMP and protein kinase in mammalian cardiomyocytes. J Biol Chem 1983;258:10233-10239.
10. Jurevicius J, Fischmeister R. cAMP compartmentation is responsible for a local activation of cardiac Ca2+ channels by beta-adrenergic agonists. Proc Natl Acad Sci USA 1996;93:295-299.
11. Chen-Izu Y, Xiao RP, Izu LT, Cheng H, Kuschel M, Spurgeon H et al. Gi-dependent localization of b2-adrenergic receptor signaling to L-Type Ca2+ channels. Biophys J 2000;79:2547-2556.
12. Fischmeister R, Castro LRV, Abi-Gerges A, Rochais F, Jurevicius J, Leroy J et al. Compartmentation of cyclic nucleotide signaling in the heart. Circ Res 2006;99:816-828.
13. Lohse MJ, Engelhardt S, Eschenhagen T. What is the role of beta-adrenergic signaling in heart failure Circ Res 2003;93:896-906.
14. Nikolaev VO, Bÿnemann M, Schmitteckert E, Lohse MJ, Engelhardt S. Cyclic AMP imaging in adult cardiac myocytes reveals far-reaching b1-adrenergic but locally confined b2-adrenergic receptor mediated signaling. Circ Res 2006;99:1084-1091.
15. Zaccolo M, Pozzan T. Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes. Science 2002;295:1711-1715.
16. Gu YC, Gorelik J, Spohr HA, Shevchuk A, Lab MJ, Harding SE et al. High-resolution scanning patch-clamp: new insights into cell function. FASEB J 2002;16:748-750.
17. Leroy J, Richter W, Mika D, Castro LRV, Abi-Gerges A, Xie M et al. Phosphodiesterase 4B in the cardiac L-type Ca2+ channel complex regulates Ca2+ current and protects against ventricular arrhythmias in mice. J Clin Invest 2011;121:2651-2661.
18. Nichols CB, Rossow CF, Navedo MF, Westenbroek RE, Catterall WA, Santana LF et al. Sympathetic stimulation of adult cardiomyocytes requires association of AKAP5 with a subpopulation of L-type calcium channels. Circ Res 2010;107:747-756.
19. Nikolaev VO, Bÿnemann M, Hein L, Hannawacker A, Lohse MJ. Novel single chain cAMP sensors for receptor-induced signal propagation. J Biol Chem 2004;279: 37215-37218.
20. Korchev YE, Negulyaev YA, Edwards CRW, Vodyanoy I, Lab MJ. Functional localization of single active ion channels on the surface of a living cell. Nat Cell Biol 2000;2: 616-619.
21. Novak P, Li C, Shevchuk AI, Stepanyan R, Caldwell M, Hughes S et al. Nanoscale livecell imaging using hopping probe ion conductance microscopy. Nat Meth 2009;6: 279-281.
22. Nikolaev VO, Moshkov A, Lyon AR, Miragoli M, Novak P, Paur H et al. b2-adrenergic receptor redistribution in heart failure changes cAMP compartmentation. Science 2010;327:1653-1657.
23. Daaka Y, Luttrell LM, Lefkowitz RJ. Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A. Nature 1997;390:88-91.
24. Xiao RP, Ji X, Lakatta EG. Functional coupling of the beta 2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes. Mol Pharmacol 1995;47:322-329.
25. Di Benedetto G, Zoccarato A, Lissandron V, Terrin A, Li X, Houslay MD et al. Protein kinase A type I and type II define distinct intracellular signaling compartments. Circ Res 2008;103:836-844.
26. Fink MA, Zakhary DR, Mackey JA, Desnoyer RW, Apperson-Hansen C, Damron DS et al. AKAP-mediated targeting of protein kinase a regulates contractility in cardiac myocytes. Circ Res 2001;88:291-297.
27. Ostrom RS, Violin JD, Coleman S, Insel PA. Selective enhancement of badrenergic receptor signaling by overexpression of adenylyl cyclase type 6: colocalization of receptor and adenylyl cyclase in caveolae of cardiac myocytes. Mol Pharmacol 2000;57: 1075-1079.
28. Rybin VO, Xu X, Lisanti MP, Steinberg SF. Differential targeting of b-adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. J Biol Chem 2000; 275:41447-41457.
29. Xiang Y, Rybin VO, Steinberg SF, Kobilka B. Caveolar localization dictates physiologic signaling of b2-adrenoceptors in neonatal cardiac myocytes. J Biol Chem 2002;277: 34280-34286.
30. Parton RG,Way M, Zorzi N, Stang E. Caveolin-3 associates with developing T-tubules during muscle differentiation. J Cell Biol 1997;136:137-154.
31. Galbiati F, Volont D, Minetti C, Chu JB, Lisanti MP. Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). J Biol Chem 1999;274:25632-25641.
32. Repetto S, Bado M, Broda P, Lucania G, Masetti E, Sotgia F et al. Increased number of caveolae and caveolin-3 overexpression in duchenne muscular dystrophy. Biochem Biophys Res Comm 1999;261:547-550.
33. Razani B, Woodman SE, Lisanti MP. Caveolae: from cell biology to animal physiology. Pharmacol Rev 2002;54:431-467.
34. Wagner E, Lauterbach MA, Kohl T, Westphal V, Williams GS, Steinbrecher JH et al. Stimulated emission depletion live-cell super-resolution imaging shows proliferative remodeling of T-tubule membrane structures after myocardial infarction. Circ Res 2012;111:402-414.
35. Woodman SE, Park DS, Cohen AW, Cheung MWC, Chandra M, Shirani J et al. Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade. J Biol Chem 2002;277:38988-38997.
36. Galbiati F, Engelman JA, Volonte D, Zhang XL, Minetti C, Li M et al. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and T-tubule abnormalities. J Biol Chem 2001; 276:21425-21433.
37. Cohen AW, Razani B, Schubert W, Williams TM, Wang XB, Iyengar P et al. Role of caveolin-1 in the modulation of lipolysis and lipid droplet formation. Diabetes 2004;53: 1261-1270.
38. Head BP, Patel HH, Roth DM, Lai NC, Niesman IR, Farquhar MG et al. G-protein-coupled receptor signaling components localize in both sarcolemmal and intracellular caveolin-3-associated microdomains in adult cardiac myocytes. J Biol Chem 2005;280:31036-31044.
39. Calaghan S, White E. Caveolae modulate excitation-contraction coupling and b2-adrenergic signalling in adult rat ventricular myocytes. Cardiovasc Res 2006;69: 816-824.
40. MacDougall DA, Agarwal SR, Stopford EA, Chu H, Collins JA, Longster AL et al. Caveolae compartmentalise b2-adrenoceptor signals by curtailing cAMP production and maintaining phosphatase activity in the sarcoplasmic reticulum of the adult ventricular myocyte. J Mol Cell Cardiol 2012;52:388-400.
41. Shenasa H, Calderone A, Vermeulen M, Paradis P, Stephens H, Cardinal R et al. Chronic doxorubicin induced cardiomyopathy in rabbits: mechanical, intracellular action potential, and badrenergic characteristics of the failing myocardium. Cardiovasc Res 1990;24:591-604.
42. Chakir K, Daya SK, Aiba T, Tunin RS, Dimaano VL, Abraham TP et al. Mechanisms of enhanced b-adrenergic reserve from cardiac resynchronization therapy. Circulation 2009;119:1231-1240.
43. Wei SK, Ruknudin A, Hanlon SU, McCurley JM, Schulze DH, Haigney MCP. Protein kinase A hyperphosphorylation increases basal current but decreases b-adrenergic responsiveness of the sarcolemmal Na+-Ca2+ exchanger in failing pig myocytes. Circ Res 2003;92:897-903.
44. Anand IS, Liu D, Chugh SS, Prahash AJC, Gupta S, John R et al. Isolated myocyte contractile function is normal in post-infarct remodeled rat heart with systolic dysfunction. Circulation 1997;96:3974-3984.
45. Miyamoto MI, del Monte F, Schmidt U, DiSalvo TS, Kang ZB, Matsui T et al. Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc Natl Acad Sci USA 2000;97:793-798.
46. Jin H, Nass RD, Joudrey PJ, Lyon AR, Chemaly ER, Rapti K et al. Altered spatiotemporal dynamics of the mitochondrial membrane potential in the hypertrophied heart. Biophys J 2010;98:2063-2071.
47. Louch WE, Bito V, Heinzel FR, Macianskiene R, Vanhaecke J, Flameng W et al. Reduced synchrony of Ca2+ release with loss of T-tubules comparison to Ca2+ release in human failing cardiomyocytes. Cardiovasc Res 2004;62:63-73.
48. Louch WE, Mørk HK, Sexton J, Strømme TA, Laake P, Sjaastad I et al. T-tubule disorganization and reduced synchrony of Ca2+ release in murine cardiomyocytes following myocardial infarction. J Physiol 2006;574:519-533.
49. Song LS, Sobie EA, McCulle S, Lederer WJ, Balke CW, Cheng H. Orphaned ryanodine receptors in the failing heart. Proc Natl Acad Sci USA 2006;103:4305-4310.
50. He JQ, Conklin MW, Foell JD, Wolff MR, Haworth RA, Coronado R et al. Reduction in density of transverse tubules and L-type Ca2+ channels in canine tachycardia-induced heart failure. Cardiovasc Res 2001;49:298-307.
51. Lyon AR, MacLeod KT, Zhang Y, Garcia E, Kanda GK, Lab MJ et al. Loss of T-tubules and other changes to surface topography in ventricular myocytes from failing human and rat heart. Proc Nat Acad Sci 2009;106:6854-6859.
52. Heinzel FR, Bito V, Biesmans L, Wu M, Detre E, von Wegner F et al. Re-modeling of T-tubules and reduced synchrony of Ca2+ release in myocytes from chronically ischemic myocardium. Circ Res 2008;102:338-346.
53. Wei S, Guo A, Chen B, Kutschke W, Xie YP, Zimmerman K et al. T-tubule remodeling during transition from hypertrophy to heart failure/novelty and significance. Circ Res 2010;107:520-531.
54. Di Maio A, Karko K, Snopko R, Mej́a-Alvarez R, Franzini-Armstrong C. T-tubule formation in cardiac myocytes: two possible mechanisms J Muscle Res Cell Motil 2007;28: 231-241.
55. Orchard C, Brette F. T-tubules and sarcoplasmic reticulum function in cardiac ventricular myocytes. Cardiovasc Res 2008;77:237-244.
56. Ziman AP, Gómez-Viquez NL, Bloch RJ, Lederer WJ. Excitation-contraction coupling changes during postnatal cardiac development. J Mol Cell Cardiol 2010;48:379-386.
57. Suetsugu S. The proposed functions of membrane curvatures mediated by the BAR domain super-family proteins. J Biochem 2010;148:1-12.
58. Lee E, Marcucci M, Daniell L, Pypaert M, Weisz OA, Ochoa GC et al. Amphiphysin 2 (Bin1) and T-tubule biogenesis in muscle. Science 2002;297:1193-1196.
59. Hong TT, Smyth JW, Gao D, Chu KY, Vogan JM, Fong TS et al. BIN1 localizes the L-type calcium channel to cardiac T-tubules. PLoS Biol 2010;8:e1000312.
60. Knö ll R, Linke WA, Zou P, Miocic S, Kostin S, Buyandelger B et al. Telethonin deficiency is associated with maladaptation to biomechanical stress in the mammalian heart/novelty and significance. Circ Res 2011;109:758-769.
61. Zhang R, Yang J, Zhu J, Xu X. Depletion of zebrafish Tcap leads to muscular dystrophy via disrupting sarcomere-membrane interaction, not sarcomere assembly. Hum Mol Genet 2009;18:4130-4140.
62. Jayasinghe I, Baddeley D, Kong C, Wehrens X, Cannell M, Soeller C. Nanoscale organization of junctophilin-2 and ryanodine receptors within peripheral couplings of rat ventricular cardiomyocytes. Biophys J 2012;102:L19-L21(Abstract).
63. Landstrom AP, Kellen CA, Dixit SS, van Oort RJ, Garbino A, Weisleder N et al. Junctophilin-2 expression silencing causes cardiocyte hypertrophy and abnormal intracellular calcium-handling/clinical perspective. Circ Heart Fail 2011;4:214-223.
64. Lyon AR, Nikolaev VO, Miragoli M, Sikkel MB, Paur H, Benard L et al. Plasticity of surface structures and b2-adrenergic receptor localization in failing ventricular cardiomyocytes during recovery from heart failure/clinical perspective. Circ Heart Fail 2012; 5:357-365.
65. Xie YP, Chen B, Sanders P, Guo A, Li Y, Zimmerman K et al. Sildenafil prevents and reverses transverse-tubule remodeling and Ca2+ handling dysfunction in right ventricle failure induced by pulmonary artery hypertension. Hypertension 2012;59: 355-362.
66. Chen B, Li Y, Jiang S, Xie YP, Guo A, KutschkeWet al. b-Adrenergic receptor antagonists ameliorate myocyte T-tubule remodeling following myocardial infarction. FASEB J 2012;26:2531-2537.
67. Sachse FB, Torres NS, Savio-Galimberti E, Aiba T, Kass DA, Tomaselli GF et al. Subcellular structures and function of myocytes impaired during heart failure are restored by cardiac resynchronization therapy/novelty and significance. Circ Res 2012;110: 588-597.
68. Ibrahim M, Navaratnarajah M, Siedlecka U, Rao C, Dias P, Moshkov AV et al. Mechanical unloading reverses transverse tubule remodelling and normalizes local Ca2+-induced Ca2+release in a rodent model of heart failure. Eur J Heart Failure 2012;14: 571-580.
69. Ibrahim M, Kukadia P, Siedlecka U, Cartledge JE, Navaratnarajah M, Tokar S et al. Cardiomyocyte Ca2+ handling and structure is regulated by degree and duration of mechanical load variation. J Cell Mol Med 2012;16:2910-2918.
70. Hong TT, Smyth JW, Chu KY, Vogan JM, Fong TS, Jensen BC et al. BIN1 is reduced and Cav1.2 trafficking is impaired in human failing cardiomyocytes. Heart Rhythm 2012;9:812-820.
71. Kaprielian RR, Stevenson S, Rothery SM, Cullen MJ, Severs NJ. Distinct patterns of dystrophin organization in myocyte sarcolemma and transverse tubules of normal and diseased human myocardium. Circulation 2000;101:2586-2594.
72. Afzal F, Andressen KW, Mork HK, Aronsen JM, Sjaastad I, Dahl CP et al. 5-HT4-elicited positive inotropic response is mediated by cAMP and regulated by PDE3 in failing rat and human cardiac ventricles. Br J Pharmacol 2008;155:1005-1014.
73. Johnson WB, Katugampola S, Able S, Napier C, Harding SE. Profiling of cAMP and cGMP phosphodiesterases in isolated ventricular cardiomyocytes from human hearts: comparison with rat and guinea pig. Life Sci 2012;90:328-336.
74. Richter W, Xie M, Scheitrum C, Krall J, Movsesian MA, Conti M. Conserved expression and functions of PDE4 in rodent and human heart. Basic Res Cardiol 2011;106: 249-262.
75. Kilts JD, Gerhardt MA, Richardson MD, Sreeram G, Mackensen GB, Grocott HP et al. Beta(2)-adrenergic and several other G protein-coupled receptors in human atrial membranes activate both G(s) and G(i). Circ Res 2000;87:705-709.
76. Paur H, Wright PT, Sikkel MB, Tranter MH, Mansfield C, O'Gara P et al. High levels of circulating epinephrine trigger apical cardiodepression in a beta2-adrenergic receptor/Gi-dependent manner: a new model of Takotsubo cardiomyopathy. Circulation 2012; 126:697-706.
77. Molenaar P, Bartel S, Cochrane A, Vetter D, Jalali H, Pohlner P et al. Both beta(2)-and beta(1)-adrenergic receptors mediate hastened relaxation and phosphorylation of phospholamban and troponin I in ventricular myocardium of Fallot infants, consistent with selective coupling of beta(2)-adrenergic receptors to G(s)-protein. Circulation 2000;102:1814-1821.
78. Levy FO, Zhu X, Kaumann AJ, Birnbaumer L. Efficacy of beta 1-adrenergic receptors is lower than that of beta 2-adrenergic receptors. Proc Natl Acad Sci USA 1993;90: 10798-10802.
79. Molenaar P, Savarimuthu SM, Sarsero D, Chen L, Semmler AB, Carle A et al. (-)-Adrenaline elicits positive inotropic, lusitropic, and biochemical effects through beta2-adrenoceptors in human atrial myocardium from nonfailing and failing hearts, consistent with Gs coupling but not with Gi coupling24. Naunyn Schmiedebergs Arch Pharmacol 2007;375:11-28.
80. Brown LA, Harding SE. The effect of pertussis toxin on beta-adrenoceptor responses in isolated cardiac myocytes from noradrenaline-treated guinea-pigs and patients with cardiac failure. Br J Pharmacol 1992;106:115-122.
81. Gong H, Sun H, Koch WJ, Rau T, Eschenhagen T, Ravens U et al. Specific beta(2)AR blocker ICI 118,551 actively decreases contraction through a G(i)-coupled form of the beta(2)AR in myocytes from failing human heart. Circulation 2002;105:2497-2503.
82. Aguero J, Almenar L, Monto F, Oliver E, Sanchez-Lazaro I, Vicente D et al. Myocardial G protein receptor-coupled kinase expression correlates with functional parameters and clinical severity in advanced heart failure. J Card Fail 2012;18:53-61.
83. Ungerer M, Parruti G, Bohm M, Puzicha M, DeBlasi A, Erdmann E et al. Expression of beta-arrestins and beta-adrenergic receptor kinases in the failing human heart. Circ Res 1994;74:206-213.
84. Aye TT, Soni S, van Veen TA, van der Heyden MA, Cappadona S, Varro A et al. Reorganized PKA-AKAP associations in the failing human heart. J Mol Cell Cardiol 2012;52: 511-518.
85. Schmidt U, Hajjar RJ, Kim CS, Lebeche D, Doye AA, Gwathmey JK. Human heart failure: cAMP stimulation of SR Ca(2+)-ATPase activity and phosphorylation level of phospholamban. Am J Physiol 1999;277:H474-H480.
86. El-Armouche A, Pohlmann L, Schlossarek S, Starbatty J, Yeh YH, Nattel S et al. Decreased phosphorylation levels of cardiac myosin-binding protein-C in human and experimental heart failure. J Mol Cell Cardiol 2007;43:223-229.
87. El-Armouche A, Pamminger T, Ditz D, Zolk O, Eschenhagen T. Decreased protein and phosphorylation level of the protein phosphatase inhibitor-1 in failing human hearts. Cardiovasc Res 2004;61:87-93.
88. Messer AE, Jacques AM, Marston SB. Troponin phosphorylation and regulatory function in human heart muscle: dephosphorylation of Ser23/24 on troponin I could account for the contractile defect in end-stage heart failure. J Mol Cell Cardiol 2007; 42:247-259.
89. Reiken S, Gaburjakova M, Guatimosim S, Gomez AM, D'Armiento J, Burkhoff D et al. Protein kinase A phosphorylation of the cardiac calcium release channel (ryanodine receptor) in normal and failing hearts. Role of phosphatases and response to isoproterenol. J Biol Chem 2003;278:444-453.
90. Schroder F, Handrock R, Beuckelmann DJ, Hirt S, Hullin R, Priebe L et al. Increased availability and open probability of single L-type calcium channels from failing compared with nonfailing human ventricle. Circulation 1998;98:969-976.
91. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 1991;325:1468-1475.
92. Kowey PR. A review of carvedilol arrhythmia data in clinical trials. J Cardiovasc Pharmacol Ther 2005;10(Suppl. 1):S59-S68.
93. Harding SE, Jones SM, Vescovo G, Del MF, Poole-Wilson PA. Reduced contractile responses to forskolin and a cyclic AMP analogue in myocytes from failing human ventricle. Eur J Pharmacol 1992;223:39-48.
94. Nef HM, Mollmann H, Akashi YJ, Hamm CW. Mechanisms of stress (Takotsubo) cardiomyopathy. Nat Rev Cardiol 2010;7:187-193.
95. Wittstein IS, Thiemann DR, Lima JAC, Baughman KL, Schulman SP, Gerstenblith G et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 2005;352:539-548.
96. Akashi YJ, Nakazawa K, Sakakibara M, Miyake F, Koike H, Sasaka K. The clinical features of takotsubo cardiomyopathy. Q J Med 2003;96:563-573.
97. Litvinov IV, Kotowycz MA, Wassmann S. Iatrogenic epinephrine-induced reverse Takotsubo cardiomyopathy: direct evidence supporting the role of catecholamines in the pathophysiology of the 'broken heart syndrome'. Clin Res Cardiol 2009;98: 457-462.
98. Lyon AR, Rees PS, Prasad S, Poole-Wilson PA, Harding SE. Stress (Takotsubo) cardiomyopathy[ mdash]a novel pathophysiological hypothesis to explain catecholamineinduced acute myocardial stunning. Nat Clin Pract Cardiovasc Med 2008;5: 22-29.
99. Ueyama T. Emotional stress-induced Tako-tsubo cardiomyopathy: animal model and molecular mechanism. Ann N Y Acad Sci 2004;1018:437-444.